MAGRX
Price
$28.67
Change
+$0.23 (+0.81%)
Updated
Dec 20 closing price
TRNEX
Price
$36.56
Change
+$0.26 (+0.72%)
Updated
Dec 20 closing price
Ad is loading...

MAGRX vs TRNEX

Header iconMAGRX vs TRNEX Comparison
Open Charts MAGRX vs TRNEXBanner chart's image
BlackRock Natural Resources Instl
Price$28.67
Change+$0.23 (+0.81%)
VolumeN/A
CapitalizationN/A
T. Rowe Price New Era I
Price$36.56
Change+$0.26 (+0.72%)
VolumeN/A
CapitalizationN/A
MAGRX vs TRNEX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MAGRX vs. TRNEX commentary
Dec 24, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MAGRX is a Hold and TRNEX is a Sell.

FUNDAMENTALS
Fundamentals
TRNEX has more cash in the bank: 2.29B vs. MAGRX (148M). TRNEX (2.97) and MAGRX (2.85) have matching dividends . MAGRX was incepted earlier than TRNEX: MAGRX (36 years) vs TRNEX (9 years). TRNEX is a more actively managed with annual turnover of: 82.80 vs. MAGRX (75.00). TRNEX has a lower initial minimum investment than MAGRX: TRNEX (500000) vs MAGRX (2000000). TRNEX annual gain was more profitable for investors over the last year : 0.39 vs. MAGRX (-6.44). MAGRX return over 5 years is better than : 33.43 vs. TRNEX (21.54).
MAGRXTRNEXMAGRX / TRNEX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence36 years9 years-
Gain YTD-6.5330.494-1,321%
Front LoadN/AN/A-
Min. Initial Investment2000000500000400%
Min. Initial Investment IRAN/AN/A-
Net Assets148M2.29B6%
Annual Yield % from dividends2.852.9796%
Returns for 1 year-6.440.39-1,667%
Returns for 3 years-0.343.00-11%
Returns for 5 years33.4321.54155%
Returns for 10 years-34.65N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LCTX0.560.06
+11.16%
Lineage Cell Therapeutics
TALK2.98-0.03
-1.00%
Talkspace
SCI81.61-0.91
-1.10%
Service Corp
CNMD68.63-1.17
-1.68%
CONMED Corp
OGEN0.36-0.02
-5.53%
Oragenics